FTM

First Turn Management Portfolio holdings

AUM $875M
1-Year Est. Return 206.38%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+206.38%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$666M
AUM Growth
+$130M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
42
New
Increased
Reduced
Closed

Top Buys

1
+$28.7M
2
+$24.6M
3
+$17.9M
4
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$13.7M
5
AKRO
Akero Therapeutics
AKRO
+$13.7M

Top Sells

1
+$29.3M
2
+$17.6M
3
+$16.2M
4
TGTX icon
TG Therapeutics
TGTX
+$16.1M
5
GH icon
Guardant Health
GH
+$15.7M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADMA icon
26
ADMA Biologics
ADMA
$2.5B
$11.9M 1.78%
808,673
-283,688
VERA icon
27
Vera Therapeutics
VERA
$2.87B
$10.3M 1.55%
354,529
+44,863
HROW icon
28
Harrow
HROW
$1.47B
$7.72M 1.16%
160,234
-68,527
MLTX icon
29
MoonLake Immunotherapeutics
MLTX
$1.24B
$1.88M 0.28%
+262,643
ALNY icon
30
Alnylam Pharmaceuticals
ALNY
$41.2B
– –
-17,879
BSX icon
31
Boston Scientific
BSX
$88.5B
– –
-138,834
GH icon
32
Guardant Health
GH
$11.9B
– –
-302,307
HQY icon
33
HealthEquity
HQY
$7.12B
– –
-80,880
ISRG icon
34
Intuitive Surgical
ISRG
$160B
– –
-32,305
KALV icon
35
KalVista Pharmaceuticals
KALV
$995M
– –
-214,138
PODD icon
36
Insulet
PODD
$13.3B
– –
-51,408
RDNT icon
37
RadNet
RDNT
$4.46B
– –
-197,759
SLNO icon
38
Soleno Therapeutics
SLNO
$2.73B
– –
-86,332
SPRY icon
39
ARS Pharmaceuticals
SPRY
$778M
– –
-455,953
TGTX icon
40
TG Therapeutics
TGTX
$5.79B
– –
-447,884
VRNA
41
DELISTED
Verona Pharma
VRNA
– –
-309,988
BBNX
42
Beta Bionics
BBNX
$547M
– –
-157,194
1
2